We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

عن NeuroAdvise

نهج عملي لعلم الأعصاب السريري

Neuro Advise is a medical application that offers a practical guide to examination, differential diagnosis and investigation of neurological conditions.

Main users are neurologists, neurosurgeons and other related professionals as well as residents, general physicians and medical students involved in neurology patient’s care.

Neuro Advise provides a unique list of differential diagnoses and diagnostic tests for any given neurology patient based on specific underlying demographic and clinical status.

Neuro Advise system database currently covers most of clinical neurological syndromes, most of neuroanatomical lesions, more than 3000 diseases and 1400 drugs in the field of clinical neurology.

Neuro Advise has several user friendly features as follows:

- Clinical approach: diagnostic approach based on clinical syndrome with a guide to neurological examination

- Anatomic approach: diagnostic approach based on neuroanatomical lesion location

- Radiologic approach: differential diagnosis for common neuro-radiologic abnormalities

Our missions are to assist physicians in making better clinical decisions and to improve patient care in clinical neurology.

تحديث لأحدث إصدار 1.1.0

Last updated on 17/07/2019

All features became free
UI improved
System performance improved
Account setting improved
Searching capability improved
Minor bugs fixed

جاري في الترجمة...

معلومات أكثر ل تطبيق

احدث اصدار

طلب NeuroAdvise تحديث 1.1.0

محمل

Abo Haidra

Android متطلبات النظام

Android 4.1+

عرض المزيد

NeuroAdvise لقطات الشاشة

اشترك في APKPure
كن أول من يحصل على الإصدارات السابقة والأخبار والأدلة لأفضل ألعاب وتطبيقات الأندرويد.
ًلا، شكرا
اشتراك
تم الاشتراك بنجاح!
أنت مشترك الآن في APKPure.
اشترك في APKPure
كن أول من يحصل على الإصدارات السابقة والأخبار والأدلة لأفضل ألعاب وتطبيقات الأندرويد.
ًلا، شكرا
اشتراك
نجاح!
لقد اشتركت في أخبار لدينا الآن لدينا.